Procalcitonin as a Biomarker for Malignant Cerebral Edema in Massive Cerebral Infarction

The objective of this study is to explore whether procalcitonin (PCT) can serve as an early biomarker of malignant cerebral edema in patients with massive cerebral infarction (MCI). Ninety-three patients with acute MCI were divided into death or survival groups based on whether they died or survived...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yan, Liu, Gang, Wang, Yuan, Su, Yingying, Leak, Rehana K., Cao, Guodong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5772664/
https://www.ncbi.nlm.nih.gov/pubmed/29343753
http://dx.doi.org/10.1038/s41598-018-19267-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5772664/
https://www.ncbi.nlm.nih.gov/pubmed/29343753
http://dx.doi.org/10.1038/s41598-018-19267-4

Ejemplares similares